Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys

Archives of Ophthalmology

Volumn 118, Issue 5, 2000, Pages 650-658

  Obana, Akira ^a   Gohto, Yuko ^a   Kanai, Masakazu ^a   Nakajima, Susumu ^b   Kaneda, Kenji ^a   Miki, Tokuhiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

13,17 BIS(1 CARBOXYPROPIONYL)CARBAMOYLETHYL 8 ETHENY 2 HYDROXY 3 HYDROXYIMINOETHYLIDENE 2,7,12,18 TETRANETHYL 6 PORPHYRIN; 4 FORMYLOXYMETHYLIDENE 3 HYDROXY 2 VINYLDEUTERIOPORPHYNYL(IX) 6,7 DIASPARTIC ACID; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFICACY; MONKEY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0034034609     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.118.5.650     Document Type: Article

References (32)

1. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials. Arch Ophthalmol. 1993;111:1200-1209.
2. Lipson RI, Baldes EJ, Olsen AM. The use of a derivative of hematoporphyrin in tumor detection. J Natl Cancer Inst. 1961;26:1-8.
3. Berenbaum MC, Hall GW, Hoyes AD. Cerebral photosensitization by haematoporphyrin derivative: evidence for an endothelial site of action. Br J Cancer. 1986; 53:81-89.
4. Nelson JS, Liaw LH, Orenstein A, Roberts WG, Berns MW. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J Natl Cancer Inst. 1988;80:1599-1605.
5. Huang AJN, Watson BD, Hernandez ZE, Tseng SCG. Photothrombosis of corneal neovascularization by intravenous rose bengal and argon laser irradiation. Arch Ophthalmol. 1989;106:680-685.
6. Corrent G, Roussel TJ, Tseng SCG, Watson BD. Promotion of graft survival by photothrombotic occlusion of corneal neovascularization Arch Ophthalmol. 1989; 107:1501-1506.
7. Epstein RJ, Hendricks RL, Harris DM. Photodynamic therapy for corneal neovascularization. Cornea. 1991;10:424-432.
8. Pallikaris IG, Tsilimbaris MK, Iliaki OE, Naoumidi II, Georgiades A, Panagopoulos IA. Effectiveness of corneal neovascularization photothrombosis using phthalocyanine and a diode laser (675 nm). Lasers Surg Med. 1993;13:197-203.
9. Tsilimbaris MK, Pallikaris IG, Naoumidi II, Vlahonikolis IG, Tsakalof AK, Lydataki SE. Phthalocyanine mediated photodynamic thrombosis of experimental corneal neovascularization: effect of phthalocyanine dose and irradiation onset time on vascular occlusion rate. Lasers Surg Med. 1994;15:19-31.
10. Obana A, Gohto Y, Matsumoto M, Miki T. Photodynamic therapy of corneal neovascularization using hematoporphyrin derivatives. J Jpn Soc Laser Med. 1996; 17:31-43.
11. Schmidt-Erfurth U, Hasan T, Schomacker K, Flotte TJ, Birngruber R. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg Med. 1995;17:178-188.
12. Packer AJ, Tse DT, Gu X-Q, Hayreh SS. Hematoporphyrin photoradiation therapy for iris neovascularization: a preliminary report. Arch Ophthalmol. 1984;102: 1193-1197.
13. Miller JW, Stinson WG, Gregory WA, El-Koumy HA, Puliafito CA. Phthalocyanine photodynamic therapy of experimental iris neovascularization. Ophthalmology. 1991;98:1711-1719.
14. Kliman GH, Puliafito CA, Stern D, Borirakchanyavat S, Gregory WA. Phthalocyanine photodynamic therapy: new strategy for closure of choroidal neovascularization. Lasers Surg Med. 1994;15:2-10.
15. Schmidt-Erfurth U, Hasan T, Gragoudas E, Michaud N, Flotte TJ, Birngruber R. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology. 1994;101:1953-1961.
16. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-derived benzoporphyrin. Ophthalmology. 1995;113:810-818.
17. Kramer M, Miller JW, Michaud N, et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Ophthalmology. 1996;103:427-438.
18. Husain D, Miller JW, Michaud N, Connolly E, Flotte TJ, Gragoudas ES. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol. 1996;114:978-985.
19. Peyman GA, Moshfeghi DM, Moshfeghi A, et al. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2), Ophthalmic Surg Lasers. 1997; 28:409-417.
20. Miller JW, Schmidt-Erfurth U, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol. 1999;117:1161-1173.
21. Schmidt-Erfurth U, Miller JW, Sickenberg M, et al. Photodynamic therapy with verteporfin tor choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol. 1999;117:1177-1187.
22. Thomas EL, Rosen R, Murphy R, et al. Purlytin (SnET2)-photodynamic therapy produces closure of subfoveal choroidal neovascularization in humans [abstract]. Invest Ophthalmol Vis Sci. 1998;39(suppl):S242.
23. Nakajima S, Sakata I, Takemura T, et al. Tumor-localizing and photosensitization of photochlorin ATX-S10. In: Spinelli S, Fante D. Marchesini R, eds. Photodynamic Therapy and Biomedical Lasers, Amsterdam, the Netherlands: Elsevier Science Publications; 1992:531-534.
24. Gohto Y, Obana A, Kaneda K, et al. Accumulation of a photosensitizer ATX-S10(Na) to experimental corneal neovascularization. J Jpn Ophthalmol Soc. 1998;102:724-730.
25. Obana A, Gohto Y, Kaneda K, et al. Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10. Lasers Surg Med. 1999;24:209-222.
26. Gohto Y, Obana A, Kaneda K, Miki T Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization. Exp Eye Res. 1998;67:313-322.
27. Ryan SJ. Development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc. 1979;77: 707-745.
28. Schmidt-Erfurth U, Michels S, Hager A, Barbazetto I, Laqua H. ICG-angiographic analysis of the photodynamic mechanism in treatment of choroidal neovascularization [abstract]. Invest Ophthalmol Vis Sci. 1998;39(suppl): S242.
29. Sunderkoetter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol. 1994;55:410-422.
30. Ishibashi T, Hata Y, Yoshikawa K, Nakagawa K, Sueishi K, Inomata H. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol. 1997;235:159-167.
31. Adamis AP, Shima DT, Yeo K-T, et al. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment endothelial cells. Biochem Biophys Res Commun. 1993;193:631-638.
32. Miller H, Miller B, Ryan SJ. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci. 1986;27:1644-1652.